Almac Adds Contained Drug Handling Capabilities
Almac's Clinical Services business unit has expanded its service offering for dispensing and bottling solid dosage products.
Almac’s Clinical Services business unit has expanded its service offering for dispensing and bottling solid dosage products by introducing enhanced containment equipment and processes at its EU and US headquarters.
Following installation and validation, the facilities are operational for companies developing potent products.
Novartis Acquisition of Regulus Therapeutics is Complete
June 25th 2025A key property included in the acquisition is farabursen, an investigational next-generation oligonucleotide targeting the microRNA miR-17 with preferential kidney exposure, intended to treat people with autosomal dominant polycystic kidney disease.
